NCT05100641: An ongoing trial by Aivita Biomedical, Inc.
This trial is ongoing. It must report results 3 years, 3 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05100641 |
|---|---|
| Title | Randomized Phase 3 Trial of Standard Care Plus AV-GBM-1 vs Autologous Monocytes as Adjunctive Therapy Following Primary Surgery Plus Concurrent Radiation-temozolomide in Patients With Newly Diagnosed Glioblastoma |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 31, 2024 |
| Completion date | March 31, 2028 |
| Required reporting date | March 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |